#Thinksabio latest news
plunges after MoonLake cites high placebo response for its inflammatory disease candidate missing the Phase 3 primary endpoint.
#Thinksabio latest news
plunges after MoonLake cites high placebo response for its inflammatory disease candidate missing the Phase 3 primary endpoint.